HOME
Universe A-Z
PSYCH STOCK NEWS
PSYCH NEWS
RESEARCH
TESTIMONIALS
CLINICAL TRIALS
CONFERENCES
2024 PSYCHEDELIC INVESTOR CONFERENCE
Search
PSYCH STOCK NEWS
2023 Watch List
2024 WATCH LIST
ALCOHOL
CHARITY
CLIENT
CLINICAL TRIALS
CLINICS
CONFERENCES
DECK
INTERVIEW
INVESTORS
IPO
LARGE CAP PSYCH
NEO
PSYCH FUND | ETF
PSYCH NEWS
PSYCH STOCK NEWS
Psychedelic Investor Guide
Psychedelic Investor TV
RESEARCH
SIDE STORIES
STUFF
SUBSCRIBE
TESTIMONIALS
UNIVERSE
VETS
VIDEOS
ATAI to Invest $50 Million in Beckley Psytech
Editor | Curator
-
January 21, 2024
NRx Pharma (NRXP) Presentation at Sachs Neuroscience Forum.
Editor | Curator
-
January 20, 2024
Silo Pharma (SILO) Takes Aim at $3.1 Billion Fibromyalgia Market.
Editor | Curator
-
January 20, 2024
Psychedelic Therapeutics Sector Outlook Released (Valhalla Ventures)
October 18, 2021
Ketamine Testimonials On Local Nashville and Miami News. Lamar Odom on...
October 16, 2021
Pasithea Therapeutics (KTTA) Opens its First Ketamine Therapy Clinic in the...
October 15, 2021
Ehave (EHVVF) To Conduct Ketamine Clinical Trial In Miami, Florida
October 13, 2021
KCSA Psychedelics Conference. Wednesday, October 13th.
October 11, 2021
Psychedelic Stock Review Initiates Coverage on Ehave Inc.
October 2, 2021
Interview: Great Interview With Cybin (CYBN) CEO Doug Drysdale.
September 29, 2021
Ehave (EHVVF) Announces Inclusion in the 2021 Psychedelic Investor Guide
September 27, 2021
Interview: Ben Lightburn, CEO of Filament Health (FLHLF). Equity.Guru
September 25, 2021
Delic (DELCF) Announces C$7.0 Million Private Placement With Institutional Investor
September 24, 2021
1
2
3
4
...
8
Page 3 of 8